These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38304322)
1. Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology. Figdore DJ; Wiste HJ; Bornhorst JA; Bateman RJ; Li Y; Graff-Radford J; Knopman DS; Vemuri P; Lowe VJ; Jr CRJ; Petersen RC; Algeciras-Schimnich A Alzheimers Dement (Amst); 2024; 16(1):e12545. PubMed ID: 38304322 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms. Dakterzada F; Cipriani R; López-Ortega R; Arias A; Riba-Llena I; Ruiz-Julián M; Huerto R; Tahan N; Matute C; Capetillo-Zarate E; Piñol-Ripoll G Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731812 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans. Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035 [TBL] [Abstract][Full Text] [Related]
4. Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathology. Silva-Spínola A; Leitão MJ; Nadal A; Le Bastard N; Santana I; Baldeiras I Alzheimers Res Ther; 2024 Mar; 16(1):51. PubMed ID: 38454502 [TBL] [Abstract][Full Text] [Related]
5. The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort. Amft M; Ortner M; Eichenlaub U; Goldhardt O; Diehl-Schmid J; Hedderich DM; Yakushev I; Grimmer T Alzheimers Res Ther; 2022 Apr; 14(1):60. PubMed ID: 35473631 [TBL] [Abstract][Full Text] [Related]
11. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN; Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591 [TBL] [Abstract][Full Text] [Related]
12. Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Keshavan A; Wellington H; Chen Z; Khatun A; Chapman M; Hart M; Cash DM; Coath W; Parker TD; Buchanan SM; Keuss SE; Harris MJ; Murray-Smith H; Heslegrave A; Fox NC; Zetterberg H; Schott JM Alzheimers Dement (Amst); 2021; 13(1):e12131. PubMed ID: 33598527 [TBL] [Abstract][Full Text] [Related]
13. Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Keshavan A; Wellington H; Chen Z; Khatun A; Chapman M; Hart M; Cash DM; Coath W; Parker TD; Buchanan SM; Keuss SE; Harris MJ; Murray-Smith H; Heslegrave A; Fox NC; Zetterberg H; Schott JM Alzheimers Dement (Amst); 2020; 12(1):e12097. PubMed ID: 32999915 [TBL] [Abstract][Full Text] [Related]
14. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease. Janelidze S; Bali D; Ashton NJ; Barthélemy NR; Vanbrabant J; Stoops E; Vanmechelen E; He Y; Dolado AO; Triana-Baltzer G; Pontecorvo MJ; Zetterberg H; Kolb H; Vandijck M; Blennow K; Bateman RJ; Hansson O Brain; 2023 Apr; 146(4):1592-1601. PubMed ID: 36087307 [TBL] [Abstract][Full Text] [Related]
15. Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment. Janelidze S; Pannee J; Mikulskis A; Chiao P; Zetterberg H; Blennow K; Hansson O JAMA Neurol; 2017 Dec; 74(12):1492-1501. PubMed ID: 29114726 [TBL] [Abstract][Full Text] [Related]